DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Carbocyclic ScaffoldsCarbocyclic Scaffolds
  5. /Benzene CompoundsBenzene Compounds
  6. /PKC|A substratePKC|A substrate
Chemical structure of CAS 915155-20-3

PKC|A substrate

CAS No.915155-20-3
MDL No.N/A
MFC69H108N24O16
MW1529.70
InChI KeyBFOXZTNYSATGMU-HVWPAQFISA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.915155-20-3
Product NamePKC|A substrate
Heavy Atom Count109Rotatable Bond Count52
Atom Stereo Count10Bond Stereo Count0
HBA21HBD24
TPSA698.220 ŲCharge0
Exact Mass1528.83751Complexity3525.49
pKa3.300XLogP-8.025

Documentation

Similar Products

  • HiBiT tag

    CAS No.1628912-54-8

  • H-Gly-asp-gly-arg-leu-tyr-ala-phe-gly-leu-NH2

    CAS No.123374-34-5

  • Alirinetide

    CAS No.725715-18-4

  • Tetanus toxin peptide

    CAS No.143651-00-7

  • H-Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu-OH

    CAS No.143228-35-7

  • Cdk5i peptide

    CAS No.2298317-00-5

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact